GlassScriptPhysician profile
Michael M Marushack
NPI 1427077593
$11,052.98
in general payments reported to CMS, 2019-2025
21 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,329 · 2020: $254 · 2021: $315 · 2022: $277 · 2023: $2,162 · 2024: $2,420 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,855 · Travel and Lodging: $2,679 · Consulting Fee: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,855.06 |
| Travel and Lodging | $2,678.90 |
| Consulting Fee | $343.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,990.33 | 2019-2022 | |
| Exactech, INC. | $3,755.25 | 2023-2025 | |
| Stryker Corporation | $1,203.95 | 2019-2025 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid, Mako |
| Hikma Pharmaceuticals USA | $343.50 | 2024 | Combogesic IV |
| Smith+Nephew, INC. | $313.70 | 2019 | |
| Davol INC. | $290.00 | 2023 | Arista Ah Flexitip |
| Zimmer Biomet Holdings, INC. | $194.81 | 2025 | G7, Persona |
| Organogenesis INC. | $178.27 | 2021 | |
| Tricoast Surgical Solutions LLC | $163.69 | 2023 | |
| Depuy Synthes Sales INC. | $160.29 | 2021-2023 | Inhance |
| Anika Therapeutics, INC. | $115.60 | 2022 | |
| Linvatec Corporation | $97.84 | 2020 | |
| Curonix LLC | $47.76 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ethicon US, LLC | $47.22 | 2021 | |
| Kci USA, INC. | $29.64 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $27.82 | 2023 | Gmk Sphere |
| Nalu Medical, INC. | $23.90 | 2023 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $22.97 | 2025 | |
| Radius Health, INC. | $17.67 | 2019 | |
| Avanos Medical | $17.22 | 2022 | |
| Boston Scientific Corporation | $11.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marushack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.